20B fundamentals
An in-depth look to BIOMARK DIAGNOSTICS INC. operating, investing, and financing activities
20B free cash flow for Q1 24 is -220.48 k EUR. For 2023, 20B free cash flow was -675.2 k EUR and operating cash flow was -672.19 k EUR.
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EUR
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
TTM